Acadia Pharmaceuticals ACAD Change in receivables
Change in receivables at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's change in receivables.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Acadia Pharmaceuticals's change in receivables?
- Acadia Pharmaceuticals (ACAD) reported change in receivables of -$13.74M in Q1 2026.
- How has Acadia Pharmaceuticals's change in receivables changed year-over-year?
- Acadia Pharmaceuticals's change in receivables decreased by 781.9% year-over-year, from $2.02M to -$13.74M.
- What does change in receivables mean?
- Change in total receivables including trade and non-trade receivables.